Journal of Clinical Apheresis

Papers
(The H4-Index of Journal of Clinical Apheresis is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue71
Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐1927
Convalescent plasma therapy in patients with COVID‐1924
Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA‐associated vasculitis23
Efficacy of convalescent plasma therapy for COVID‐19: A systematic review and meta‐analysis18
Ninety days transplant free survival with high volume plasma exchange in Wilson disease presenting as acute liver failure16
The role of double filtration plasmapheresis in hypertriglyceridemic pancreatitis: A propensity score matching analysis16
Refractory vaccine‐induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE)15
Anti‐MDA‐5 antibody‐positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease treated with therapeutic plasma exchange: A case series13
Unstimulated apheresis for chimeric antigen receptor manufacturing in pediatric/adolescent acute lymphoblastic leukemia patients13
The use of therapeutic plasma exchange as adjunctive therapy in the treatment of coronavirus disease 2019: A critical appraisal of the current evidence13
Red blood cell exchange to avoid intubating a COVID‐19 positive patient with sickle cell disease?13
A matched cohort study of convalescent plasma therapy for COVID‐1912
0.019850015640259